Skip to main content
SpringerLink
Log in

Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1)

  • Brief report
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. S.S. Guo, M.P. Sawicki, Molecular and genetic mechanisms of tumorigenes in multiple endocrine neoplasia type-1. Mol. Endocrinol. 15, 1653–1664 (2001)

    Article  CAS  PubMed  Google Scholar 

  2. G. Effraimidis, U. Knigge, M. Rossing, P. Oturai, Å.K. Rasmussen, U. Feldt-Rasmussen, Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs). Semin. Cancer Biol. 79, 141–162 (2022)

    Article  CAS  PubMed  Google Scholar 

  3. R.V. Thakker, P.J. Newey, G.V. Walls et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97, 2990–3011 (2012)

    Article  CAS  PubMed  Google Scholar 

  4. B. Niederle, A. Selberherr, D.K. Bartsch et al. Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome – an international consensus statement. Neuroendocrinology 111, 609–630 (2021)

    Article  CAS  PubMed  Google Scholar 

  5. G.M. Doherty, Multiple endocrine neoplasia type 1: duodenopancreatic tumors. Surg. Oncol. 12, 135–143 (2003)

    Article  PubMed  Google Scholar 

  6. M.A. Kouvaraki, S.E. Shapiro, G.J. Cote et al. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J. Surg. 30, 643–653 (2006)

    Article  PubMed  Google Scholar 

  7. M. Falconi, B. Eriksson, G. Kaltsas et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103, 153–171 (2016)

    Article  CAS  PubMed  Google Scholar 

  8. L. Camera, S. Paoletta, C. Mollica et al. Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound. Radio. Med. 116, 595–606 (2011)

    Article  CAS  Google Scholar 

  9. C. Barbe, A. Murat, B. Dupas et al. Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumors in multiple endocrine neoplasia type-1. Dig. Liv Dis. 44, 228–234 (2012)

    Article  Google Scholar 

  10. I.D. Nagtegaal, R.D. Odze, D. Klimstra et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 76, 182–188 (2020)

    Article  PubMed  Google Scholar 

  11. C. Cappelli, U. Boggi, S. Mazzeo et al. Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours. Eur. Radio. 25, 751–759 (2015)

    Article  Google Scholar 

  12. E. Belousova, G. Karmazanovsky, A. Kriger et al. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades. Clin. Radio. 72, 150–158 (2017)

    Article  CAS  Google Scholar 

  13. F. Salahshour, M.M. Mehrabinejad, A. Zare Dehnavi et al. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades. Abdom. Radio. 45, 3155–3162 (2020)

    Article  Google Scholar 

  14. S. Chiloiro, F. Lanza, A. Bianchi, G. et al. Pancreatic neuroendocrine tumors in MEN-1 disease: a monocentric longitudinal and prognostic study. Endocrine 60, 362–367 (2018). https://doi.org/10.1007/S12020-017-1327-0

  15. V. Ramundo, M. Del Prete, V. Marotta et al. Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours. Clin. Endocrinol. 80, 850–855 (2014)

    Article  CAS  Google Scholar 

  16. A. Faggiano, R. Modica, F. Lo Calzo et al. Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors < 2 centimeters. J. Clin. Endocrinol. Metab. 105, dgz007 (2020). https://doi.org/10.1210/clinem/dgz007

  17. S. Lastoria, F. Marciello, A. Faggiano et al. Role of 68Ga-DOTATATE PET/CT in patients with multiple nedocrine neoplasia type 1 (MEN1). Endocrine 52, 488–494 (2016). https://doi.org/10.1007/s12020-015-0702y

  18. N. Lévy-Bohbot, C. Merle, P. Goudet et al. Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterol. Clin. Biol. 28, 1075–1081 (2004)

    Article  PubMed  Google Scholar 

  19. F. Tonelli, G. Fratini, G. Nesi et al. Pancreatectomy in multiple endocrine neoplasia type-1 related gastrinomas and pancreatic endocrine neoplasia. Ann. Surg. 244, 61–70 (2006)

    Article  PubMed  PubMed Central  Google Scholar 

  20. R. Casadei, C. Ricci, G. Taffurelli et al. Is total pancreatectomy as feasible, safe, efficacious and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study. J. Gastrointest. Surg. 20, 1595–1607 (2016). https://doi.org/10.1007/s11605-016-3201-4

Download references

Author information

Authors and Affiliations

  1. Department of Advanced Biomedical Sciences, Section of Radiology, University “Federico II”, Naples, Italy

    Luigi Camera, Francesca Boccadifuoco, Valeria Romeo, Simone Maurea & Arturo Brunetti

  2. Department of Endocrinology, University “Federico II”, Naples, Italy

    Roberta Modica & Annamaria Colao

  3. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

    Luca Messerini

  4. Department of Endocrinology, University “La Sapienza”, Rome, Italy

    Antongiulio Faggiano

  5. Department of Advanced Biomedical Sciences, Section of Nuclear Medicine, University “Federico II”, Naples, Italy

    Valeria Gaudieri

Authors
  1. Luigi Camera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesca Boccadifuoco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberta Modica
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luca Messerini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antongiulio Faggiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Valeria Romeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Valeria Gaudieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Annamaria Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Simone Maurea
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Arturo Brunetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the European Neuroendocrine Tumor Society (ENETS) of Naples

Contributions

L.C.: conceptual design and manuscript draft. F.B.: data collection and literature search. R.M.: referring physician. L.M.: histopathological analysis. A.F.: manuscript revision. V.R.: MR study. V.G.: PPRT. A.C.: manuscript revision. S.M.: manuscript revision. A.B.: manuscript editing.

Corresponding author

Correspondence to Luigi Camera.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics approval

This is an observational study. The Local Ethical Committee declared that no ethical approval is required.

Informed consent

Written informed consent was obtained by the patient for both.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Camera, L., Boccadifuoco, F., Modica, R. et al. Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1). Endocrine 81, 459–463 (2023). https://doi.org/10.1007/s12020-023-03373-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-023-03373-z

Search

Navigation